Published in Arthritis Res Ther on January 01, 2006
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol (2010) 5.14
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol (2010) 3.14
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis (2013) 2.39
Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis (2008) 1.82
Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther (2012) 1.79
The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm (2014) 1.76
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A (2011) 1.59
Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. Immunity (2013) 1.50
Direct in vivo evidence of activated macrophages in human osteoarthritis. Osteoarthritis Cartilage (2016) 1.41
Immunopathogenesis of osteoarthritis. Clin Immunol (2013) 1.29
Effect of low-level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Arthritis Res Ther (2013) 1.29
Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice. Arthritis Rheum (2013) 1.25
High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther (2010) 1.24
Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum (2011) 1.12
Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc (2014) 1.08
The role of ADAMTSs in arthritis. Protein Cell (2010) 1.03
Osteoarthritis: can anti-cytokine therapy play a role in treatment? Clin Rheumatol (2010) 1.02
A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials (2011) 0.99
Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study. Clin Orthop Relat Res (2008) 0.99
Evaluation of cartilage degradation in arthritis using T1ρ magnetic resonance imaging mapping. Rheumatol Int (2011) 0.98
Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder. J Biomed Biotechnol (2011) 0.98
Osteoarthritis pain mechanisms: basic studies in animal models. Osteoarthritis Cartilage (2013) 0.98
Comparative analysis of two low-level laser doses on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Lasers Med Sci (2013) 0.97
Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J (2010) 0.94
In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage. Arthritis Res Ther (2009) 0.93
The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol (2015) 0.92
Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages. J Ethnopharmacol (2011) 0.92
Characterisation of synovial fluid and infrapatellar fat pad derived mesenchymal stromal cells: The influence of tissue source and inflammatory stimulus. Sci Rep (2016) 0.90
The association between leptin, interleukin-6, and hip radiographic osteoarthritis in older people: a cross-sectional study. Arthritis Res Ther (2010) 0.90
Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int J Mol Sci (2012) 0.90
Inflammatory response in patients with active and inactive osteoarthritis. Rheumatol Int (2009) 0.90
Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Curr Rheumatol Rep (2012) 0.90
CD11c(+) macrophages and levels of TNF-α and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia. Clin Exp Immunol (2015) 0.85
Arthroscopic assessment of stifle synovitis in dogs with cranial cruciate ligament rupture. PLoS One (2014) 0.85
Control of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes. PLoS One (2011) 0.84
Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes. Arthritis Res Ther (2013) 0.84
Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage (2015) 0.84
Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia. J Vet Sci (2008) 0.83
Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3. J Orthop Traumatol (2011) 0.82
Unicompartmental and bicompartmental knee osteoarthritis show different patterns of mononuclear cell infiltration and cytokine release in the affected joints. Clin Exp Immunol (2015) 0.82
Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers (2016) 0.81
Synovial macrophage-derived IL-1β regulates the calcitonin receptor in osteoarthritic mice. Clin Exp Immunol (2015) 0.81
Matrix-embedded cytokines to simulate osteoarthritis-like cartilage microenvironments. Tissue Eng Part A (2013) 0.80
Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage. Arthritis Res Ther (2014) 0.80
Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford) (2014) 0.79
Pulsed electromagnetic fields decrease proinflammatory cytokine secretion (IL-1β and TNF-α) on human fibroblast-like cell culture. Rheumatol Int (2010) 0.78
Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine. Arthritis Res Ther (2011) 0.78
From osteoarthritic synovium to synovial-derived cells characterization: synovial macrophages are key effector cells. Arthritis Res Ther (2016) 0.77
Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells. Tissue Eng Part A (2014) 0.77
Characterizing heterogeneity in the response of synovial mesenchymal progenitor cells to synovial macrophages in normal individuals and patients with osteoarthritis. J Inflamm (Lond) (2016) 0.77
Adiponectin enhances intercellular adhesion molecule-1 expression and promotes monocyte adhesion in human synovial fibroblasts. PLoS One (2014) 0.77
Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation. Osteoarthritis Cartilage (2016) 0.77
Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis. Arthritis Res Ther (2013) 0.76
Diverse expression of selected cytokines and proteinases in synovial fluid obtained from osteoarthritic and healthy human knee joints. Eur J Med Res (2014) 0.76
The fluence effects of low-level laser therapy on inflammation, fibroblast-like synoviocytes, and synovial apoptosis in rats with adjuvant-induced arthritis. Photomed Laser Surg (2014) 0.76
Immediate Administration of Intraarticular Triamcinolone Acetonide After Joint Injury Modulates Molecular Outcomes Associated With Early Synovitis. Arthritis Rheumatol (2016) 0.76
Conditional macrophage depletion increases inflammation and does not inhibit the development of osteoarthritis in obese MaFIA mice. Arthritis Rheumatol (2017) 0.76
Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. Arthritis Res Ther (2016) 0.76
FOXO1, PXK, PYCARD and SAMD9L are differentially expressed by fibroblast-like cells in equine synovial membrane compared to joint capsule. BMC Vet Res (2017) 0.75
Synoviocytes protect cartilage from the effects of injury in vitro. BMC Musculoskelet Disord (2013) 0.75
The cytokine expression in synovial membrane and the relationship with pain and pathological findings at hip arthroscopy. J Exp Orthop (2017) 0.75
Analgesic and anti-Inflammatory effect of UP3005, a botanical composition Containing two standardized extracts of Uncaria gambir and Morus alba. Pharmacognosy Res (2015) 0.75
A Three-Dimensional Chondrocyte-Macrophage Coculture System to Probe Inflammation in Experimental Osteoarthritis. Tissue Eng Part A (2016) 0.75
Chondroprotective effect of high-molecular-weight hyaluronic acid on osteoarthritic chondrocytes in a co-cultivation inflammation model with M1 macrophages. J Inflamm (Lond) (2016) 0.75
What is the effect of nicotinic acetylcholine receptor stimulation on osteoarthritis in a rodent animal model? SAGE Open Med (2016) 0.75
Andrographolide Exerts Chondroprotective Activity in Equine Cartilage Explant and Suppresses Interleukin-1 β -Induced MMP-2 Expression in Equine Chondrocyte Culture. Int Sch Res Notices (2014) 0.75
Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints. J Vet Sci (2014) 0.75
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. Arthritis Res Ther (2016) 0.75
Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874. BMC Med Genet (2015) 0.75
MicroRNA-33 suppresses CCL2 expression in chondrocytes. Biosci Rep (2016) 0.75
Radiological and biochemical effects (CTX-II, MMP-3, 8, and 13) of low-level laser therapy (LLLT) in chronic osteoarthritis in Al-Kharj, Saudi Arabia. Lasers Med Sci (2016) 0.75
A Brief History of IL-1 and IL-1 Ra in Rheumatology. Front Pharmacol (2017) 0.75
Mechano growth factor-E regulates apoptosis and inflammatory responses in fibroblast-like synoviocytes of knee osteoarthritis. Int Orthop (2015) 0.75
IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells. Sci Rep (2017) 0.75
Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model. J Control Release (2017) 0.75
Tocilizumab (Actemra). Hum Vaccin Immunother (2017) 0.75
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature (2005) 5.71
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum (2001) 5.24
Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet (1989) 4.42
Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol (2002) 4.37
The role of cytokines in osteoarthritis pathophysiology. Biorheology (2002) 4.28
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature (2005) 4.24
Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis (2005) 3.25
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum (1999) 2.36
Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques (1997) 2.36
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem (1999) 2.33
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis (2000) 2.32
Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum (2003) 2.15
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis (1993) 2.01
Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc Natl Acad Sci U S A (1998) 2.01
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum (2004) 2.01
Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol (2000) 1.99
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum (2002) 1.97
Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum (1994) 1.93
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage (2001) 1.86
Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum (2003) 1.82
Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum (2005) 1.81
The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res (1999) 1.67
Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci (1999) 1.67
Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs. Arthritis Rheum (2005) 1.65
Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol (2005) 1.55
Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A (1999) 1.54
Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis (2000) 1.52
Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage (2004) 1.47
Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum (2002) 1.40
C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage (2002) 1.39
Cytokine production in culture by cells isolated from the synovial membrane. J Autoimmun (1989) 1.33
Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum (2004) 1.32
Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J (2000) 1.26
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J (1999) 1.18
Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum (2001) 1.12
Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis (2006) 1.09
Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy. Arthritis Rheum (2003) 1.08
Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependent. Rheumatology (Oxford) (2006) 1.05
CD45-induced tumor necrosis factor alpha production in monocytes is phosphatidylinositol 3-kinase-dependent and nuclear factor-kappaB-independent. J Biol Chem (1999) 1.05
Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther (2001) 1.02
Degradative enzymes in osteoarthritis. Front Biosci (1999) 0.99
Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis (2002) 0.99
Retracted Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum (2002) 0.99
Usefulness of high resolution US in the evaluation of effusion in osteoarthritic first carpometacarpal joint. Scand J Rheumatol (2000) 0.97
Design and synthetic considerations of matrix metalloproteinase inhibitors. Ann N Y Acad Sci (1999) 0.89
High resolution ultrasonography in detection of bone erosions in patients with hand osteoarthritis. J Rheumatol (2005) 0.86
Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation. In Vitro Cell Dev Biol Anim (1998) 0.86
An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients. Matrix Biol (2006) 0.82
Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications. Ann N Y Acad Sci (1999) 0.80
Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum (2005) 1.65
Binding and localization of recombinant lubricin to articular cartilage surfaces. J Orthop Res (2007) 1.34
Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) in tendon. Matrix Biol (2002) 1.32
Chondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cells. J Histochem Cytochem (2007) 1.22
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol (2002) 1.14
Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues. Arthritis Res Ther (2008) 1.09
Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. J Immunol (2009) 1.09
Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase. Proc Natl Acad Sci U S A (2006) 1.02
Retracted Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum (2002) 0.99
Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system. Arthritis Rheum (2007) 0.98
Retracted Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc (2002) 0.93
Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. J Biol Chem (2012) 0.92
Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease. PLoS One (2013) 0.88
Differential expression of the keratan sulphate proteoglycan, keratocan, during chick corneal embryogenesis. Histochem Cell Biol (2007) 0.87
Antibodies and immunohistochemistry in extracellular matrix research. Methods (2008) 0.85
Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. J Zhejiang Univ Sci B (2008) 0.84
Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage. Arthritis Rheum (2002) 0.83
Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis. Am J Vet Res (2005) 0.83
An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients. Matrix Biol (2006) 0.82
Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues. World J Gastroenterol (2012) 0.81
Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development. Histochem Cell Biol (2012) 0.81
Generation of anti-complement "prodrugs": cleavable reagents for specific delivery of complement regulators to disease sites. J Biol Chem (2003) 0.80
ADAMTS-4_v1 is a splice variant of ADAMTS-4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain. Arthritis Rheum (2013) 0.79
Immunochemical localization of keratan sulfate proteoglycans in cornea, sclera, and limbus using a keratanase-generated neoepitope monoclonal antibody. Invest Ophthalmol Vis Sci (2008) 0.78
Proteoglycan metabolism, cell death and Kashin-Beck disease. Glycoconj J (2012) 0.77
The effect of beta-xylosides on the chondrogenic differentiation of mesenchymal stem cells. Histochem Cell Biol (2012) 0.76
Modification of palm oil for anti-inflammatory nutraceutical properties. Lipids (2009) 0.75
Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc (2006) 0.75
Altered proteolytic activity and expression of MMPs and aggrecanases and their inhibitors in Kashin-Beck disease. J Orthop Res (2014) 0.75